Rosemont Pharmaceuticals
Raveendra Yarramasu is a Quality Control Analyst at Rosemont Pharmaceuticals since June 2022, performing physical and analytical tests on finished products while adhering to GMP guidelines and utilizing HPLC and TLC techniques. Previously, Raveendra worked as a Laboratory Technician at Target Healthcare Limited, focusing on converting solid dosage forms to liquids for dysphagia patients, and completed an internship at Bristol Laboratories Ltd., gaining substantial knowledge in manufacturing and quality assurance processes. Raveendra's academic background includes a Master's in Pharmaceutical Science with Industrial Practice from the University of Greenwich, where A grades were achieved in all modules. An earlier internship at Aurabindho Pharmaceuticals provided foundational experience in quality assurance and laboratory analysis within the pharmaceuticals sector.
Rosemont Pharmaceuticals
At Rosemont our mission is to be a rapid developer, reliable manufacturer and global supplier of novel-delivery, patient-focused medicines. Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges. At Rosemont we have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products. All of our products, both licensed and ‘specials’ are made to the same exacting standards under GMP. Our UK range also includes 9 products licensed for use with PEG/NG tubes. We are always seeking to expand our range of medicines and covert our ‘specials’ to licensed product wherever possible.